Vanderbilt University Medical Center (VUMC)
Playback speed
10 seconds
Genomic Signatures in Adjuvant Therapy of HR+ EBC: Should We Consider Abemaciclib x2 Years to ET in Very-High Risk Patients? Can Longer CDK4/6i Duration Prevent Late Relapses?
212 views
February 28, 2021
Login to view comments.
Click here to Login